These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8118938)
1. DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems. Pathak DN; Bodell WJ Carcinogenesis; 1994 Mar; 15(3):529-32. PubMed ID: 8118938 [TBL] [Abstract][Full Text] [Related]
2. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen. Pathak DN; Pongracz K; Bodell WJ Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794 [TBL] [Abstract][Full Text] [Related]
3. Activation of the tamoxifen derivative metabolite E to form DNA adducts: comparison with the adducts formed by microsomal activation of tamoxifen. Pongracz K; Pathak DN; Nakamura T; Burlingame AL; Bodell WJ Cancer Res; 1995 Jul; 55(14):3012-5. PubMed ID: 7606720 [TBL] [Abstract][Full Text] [Related]
4. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo. Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775 [TBL] [Abstract][Full Text] [Related]
5. Formation of DNA adducts by microsomal and peroxidase activation of p-cresol: role of quinone methide in DNA adduct formation. Gaikwad NW; Bodell WJ Chem Biol Interact; 2001 Dec; 138(3):217-29. PubMed ID: 11714480 [TBL] [Abstract][Full Text] [Related]
6. Examination of microsomal cytochrome P450-catalyzed in vitro activation of o-phenylphenol to DNA binding metabolite(s) by 32P-postlabeling technique. Pathak DN; Roy D Carcinogenesis; 1992 Sep; 13(9):1593-7. PubMed ID: 1394845 [TBL] [Abstract][Full Text] [Related]
7. Production of 8-hydroxy-2'-deoxguanosine in DNA by microsomal activation of tamoxifen and 4-hydroxytamoxifen. Ye Q; Bodell WJ Carcinogenesis; 1996 Aug; 17(8):1747-50. PubMed ID: 8761436 [TBL] [Abstract][Full Text] [Related]
8. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2. Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241 [TBL] [Abstract][Full Text] [Related]
9. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro. Hemminki K; Widlak P; Hou SM Carcinogenesis; 1995 Jul; 16(7):1661-4. PubMed ID: 7614704 [TBL] [Abstract][Full Text] [Related]
10. DNA adduction by polychlorinated biphenyls: adducts derived from hepatic microsomal activation and from synthetic metabolites. Pereg D; Robertson LW; Gupta RC Chem Biol Interact; 2002 Feb; 139(2):129-44. PubMed ID: 11823002 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the formation of the major diethylstilbestrol-DNA adduct and some evidence of its structure. Bhat HK; Han X; Gladek A; Liehr JG Carcinogenesis; 1994 Oct; 15(10):2137-42. PubMed ID: 7955045 [TBL] [Abstract][Full Text] [Related]
12. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase. Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579 [TBL] [Abstract][Full Text] [Related]
13. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy. Stiborová M; Hájek M; Frei E; Schmeiser HH Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648 [TBL] [Abstract][Full Text] [Related]
14. In vivo DNA adduct formation by bisphenol A. Atkinson A; Roy D Environ Mol Mutagen; 1995; 26(1):60-6. PubMed ID: 7641708 [TBL] [Abstract][Full Text] [Related]
15. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite. Randerath K; Moorthy B; Mabon N; Sriram P Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037 [TBL] [Abstract][Full Text] [Related]
16. DNA adducts of the ubiquitous environmental contaminant cyclopenta[cd]pyrene. Beach AC; Gupta RC Carcinogenesis; 1994 May; 15(5):1065-72. PubMed ID: 8200070 [TBL] [Abstract][Full Text] [Related]
17. Comparative 32P-postlabeling analysis of benzo[a]pyrene--DNA adducts formed in vitro upon activation of benzo[a]pyrene by human, rabbit and rodent liver microsomes. Roggeband R; Wolterbeek AP; Rutten AA; Baan RA Carcinogenesis; 1993 Sep; 14(9):1945-50. PubMed ID: 8403223 [TBL] [Abstract][Full Text] [Related]
18. Covalent modification of DNA by daunorubicin. Purewal M; Liehr JG Cancer Chemother Pharmacol; 1993; 33(3):239-44. PubMed ID: 8269605 [TBL] [Abstract][Full Text] [Related]
19. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts. Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506 [TBL] [Abstract][Full Text] [Related]
20. Bioactivation of tamoxifen by recombinant human cytochrome p450 enzymes. Notley LM; De Wolf CJ; Wunsch RM; Lancaster RG; Gillam EM Chem Res Toxicol; 2002 May; 15(5):614-22. PubMed ID: 12018981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]